Ovarian cancer

By Mayo Clinic Staff
May 02, 2025

Research

Mayo Clinic has been recognized as a Specialized Program of Research Excellence (SPORE) for ovarian cancer research, funded by the National Cancer Institute. Learn more about the Mayo Clinic Ovarian Cancer SPORE.

Ovarian cancer research is conducted in coordination with the Mayo Clinic Comprehensive Cancer Center, which has been designated a comprehensive cancer center in recognition of scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

Publications

See a list of publications about ovarian cancer by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

  1. Hoffman BL, et al. Epithelial ovarian cancer. In: Williams Gynecology. 4th ed. McGraw Hill; 2020. https://accessmedicine.mhmedical.com. Accessed May 5, 2021.
  2. Niederhuber JE, et al., eds. Carcinoma of the ovaries and fallopian tubes. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed May 5, 2021.
  3. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1453. Accessed May 5, 2021.
  4. Ovarian, fallopian tube and primary peritoneal cancer prevention (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/ovarian/patient/ovarian-prevention-pdq. Accessed May 5, 2021.
  5. Van Stein RM, et al. Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer. JAMA Oncology. 2021; doi:10.1001/jamaoncol.2021.0580.
  6. Palliative care. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1454. Accessed May 5, 2021.
  7. Ovarian SPOREs. National Cancer Institute. https://trp.cancer.gov/spores/ovarian.htm. Accessed May 5, 2021.
  8. Warner KJ. Allscripts EPSi. Mayo Clinic. Feb. 26, 2021.
  9. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed May 5, 2021.
  10. Genetic/familial high-risk assessment: Breast, ovarian and pancreatic. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1503. Accessed June 24, 2021.
  11. Gershenson DM, et al. Management of low-grade, serous carcinoma of the ovary. https://www.uptodate.com/contents/search. Accessed June 25, 2021.